Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 39, Issue 3, March 2014, Pages 177-240
 
MONOGRAPHS
 
  
 Otlertuzumab.
Anti-CD37 monoclonal antibody, Apoptosis inducer, Treatment of B-cell malignancies.
Haddley, K.
Drugs Fut 2014, 39(3): 177
Summary | Full Text: PDF 
 
  
  
 Tralokinumab.
Anti-interleukin-13 monoclonal antibody, Treatment of asthma, Treatment of idiopathic pulmonary fibrosis.
Walsh, G.M.
Drugs Fut 2014, 39(3): 183
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLES
 
  
 An overview on breast cancer: the standpoint of research programs, current standard of care and future goals.
Romano, G.
Drugs Fut 2014, 39(3): 189
Summary | Full Text: PDF 
 
  
  
 Telomerase inhibitors and vaccines for the treatment of cancer.
Pento, J.T.
Drugs Fut 2014, 39(3): 201
Summary | Full Text: PDF 
 
  
  
 WEE1 inhibition as anticancer strategy: first advances.
Brana, I., Mackay, H.
Drugs Fut 2014, 39(3): 207
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Navarro, D., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2014, 39(3): 223
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 The 32nd Annual JP Morgan Healthcare Conference (Part VI) – A presentation by Array BioPharma, San Francisco, California, USA – January 13-16, 2014.
McNamara, Y.
Drugs Fut 2014, 39(3): 231
Summary | Full Text: PDF 
 
  
  
 The 32nd Annual JP Morgan Healthcare Conference (Part VIII) – A presentation by Morphosys, San Francisco, California, USA – January 13-16, 2014.
McNamara, Y.
Drugs Fut 2014, 39(3): 233
Summary | Full Text: PDF 
 
  
  
 The 32nd Annual JP Morgan Healthcare Conference (Part XI) – A presentation by Lexicon Pharmaceuticals, San Francisco, California, USA – January 13-16, 2014.
Croasdell, G.
Drugs Fut 2014, 39(3): 235
Summary | Full Text: PDF 
 
  
  
 The 32nd Annual JP Morgan Healthcare Conference (Part XVI) – A presentation by Sangamo BioSciences, San Francisco, California, USA – January 13-16, 2014.
Sharman, R.
Drugs Fut 2014, 39(3): 237
Summary | Full Text: PDF 
 
  
  
 The 32nd Annual JP Morgan Healthcare Conference (Part XIX) – A presentation by Prosensa Therapeutics, San Francisco, California, USA – January 13-16, 2014.
Sharman, R.
Drugs Fut 2014, 39(3): 239
Summary | Full Text: PDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy